Drug
SCT510 clinical trials
Also written SCT510.
- studies test it
- 3
- open now
- 0
- in phase 3
- 2
- first study started
- 2018
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
3 studies that test it; most in 2018 (1)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 1
- Phase 3
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 1
Sinocelltech Ltd. (2) · First Affiliated Hospital of Zhejiang University (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses SCT510 is read from its arms, and is right about nine times in ten.
Testing it · 3
- SCT-I10A Plus SCT510 Versus Sorafenib as First-Line Therapy for Advanced Hepatocellular CarcinomaActive, not recruitingPhase 2/3Sinocelltech Ltd.NCT04560894Written as SCT510
- PK and Safety of SCT510CompletedPhase 1First Affiliated Hospital of Zhejiang UniversityNCT05113511Written as SCT510
- To Evaluate the Efficacy and Safety of SCT510 in the Treatment of Non-small Cell Lung CancerStatus unknownPhase 3Sinocelltech Ltd.NCT03792074Written as SCT510